Aging of tissue-resident adult stem/progenitor cells and their pathological consequences

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

adult stem/progenitor cells or molecular targeting of their malignant counterpart, cancer stem/progenitor cells may constitute potential anti-aging and cancer therapies. These therapeutic strategies could be used for treating diverse devastating premature aging and age-related disorders including hematopoietic and immune disorders, heart failure and cardiovascular diseases, neurodegenerative, muscular and gastrointestinal diseases, atherosclerosis and aggressive and lethal cancers.

Original languageEnglish (US)
Pages (from-to)57-79
Number of pages23
JournalPanminerva Medica
Volume51
Issue number2
StatePublished - Jun 1 2009

Fingerprint

Adult Stem Cells
Stem Cells
Premature Aging
Neoplastic Stem Cells
Gastrointestinal Diseases
Immune System Diseases
Muscular Diseases
Neurodegenerative Diseases
Heart Diseases
Neoplasms
Atherosclerosis
Cardiovascular Diseases
Heart Failure
Therapeutics

Keywords

  • Adult stem cells
  • Cell aging
  • Neoplasms
  • Neoplastic stem cells
  • Neurodegenerative diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Aging of tissue-resident adult stem/progenitor cells and their pathological consequences. / Mimeault, M.; Batra, Surinder Kumar.

In: Panminerva Medica, Vol. 51, No. 2, 01.06.2009, p. 57-79.

Research output: Contribution to journalArticle

@article{07f5aaca86f546908352fd45bfe241d5,
title = "Aging of tissue-resident adult stem/progenitor cells and their pathological consequences",
abstract = "adult stem/progenitor cells or molecular targeting of their malignant counterpart, cancer stem/progenitor cells may constitute potential anti-aging and cancer therapies. These therapeutic strategies could be used for treating diverse devastating premature aging and age-related disorders including hematopoietic and immune disorders, heart failure and cardiovascular diseases, neurodegenerative, muscular and gastrointestinal diseases, atherosclerosis and aggressive and lethal cancers.",
keywords = "Adult stem cells, Cell aging, Neoplasms, Neoplastic stem cells, Neurodegenerative diseases",
author = "M. Mimeault and Batra, {Surinder Kumar}",
year = "2009",
month = "6",
day = "1",
language = "English (US)",
volume = "51",
pages = "57--79",
journal = "Panminerva Medica",
issn = "0031-0808",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Aging of tissue-resident adult stem/progenitor cells and their pathological consequences

AU - Mimeault, M.

AU - Batra, Surinder Kumar

PY - 2009/6/1

Y1 - 2009/6/1

N2 - adult stem/progenitor cells or molecular targeting of their malignant counterpart, cancer stem/progenitor cells may constitute potential anti-aging and cancer therapies. These therapeutic strategies could be used for treating diverse devastating premature aging and age-related disorders including hematopoietic and immune disorders, heart failure and cardiovascular diseases, neurodegenerative, muscular and gastrointestinal diseases, atherosclerosis and aggressive and lethal cancers.

AB - adult stem/progenitor cells or molecular targeting of their malignant counterpart, cancer stem/progenitor cells may constitute potential anti-aging and cancer therapies. These therapeutic strategies could be used for treating diverse devastating premature aging and age-related disorders including hematopoietic and immune disorders, heart failure and cardiovascular diseases, neurodegenerative, muscular and gastrointestinal diseases, atherosclerosis and aggressive and lethal cancers.

KW - Adult stem cells

KW - Cell aging

KW - Neoplasms

KW - Neoplastic stem cells

KW - Neurodegenerative diseases

UR - http://www.scopus.com/inward/record.url?scp=72949124837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949124837&partnerID=8YFLogxK

M3 - Article

C2 - 19776709

AN - SCOPUS:72949124837

VL - 51

SP - 57

EP - 79

JO - Panminerva Medica

JF - Panminerva Medica

SN - 0031-0808

IS - 2

ER -